TCR2 prices $75M IPO at midpoint

TCR2 Therapeutics Inc. (NASDAQ:TCRR) raised $75 million in an IPO priced late Wednesday. The company added $0.07 to $15.07 in its first day of trading Thursday.

The immuno-oncology company priced 5 million shares at $15, the midpoint of its range of $14-$16. The price valued TCR2 at $347.8 million...